Comparative study of primary and recurrent ovarian serous carcinomas: Comparative genomic hybridization analysis with a potential application for prognosis

Gynecologic Oncology

Volumn 89, Issue 3, 2003, Pages 369-375

  Hu, J ^a,b   Khanna, V ^b   Jones, M W ^b   Surti, U ^b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 5P; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME IDENTIFICATION; CHROMOSOME LOSS; CHROMOSOME MUTATION; CHROMOSOME XP; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENETIC CODE; HUMAN; HUMAN TISSUE; MUTATION RATE; ONCOGENE MYC; OVARY CARCINOMA; PRIORITY JOURNAL; RECURRENT CANCER; SURVIVAL TIME;

EID: 0038208175     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00056-8     Document Type: Article

References (20)

1. Tanaka K., Boice C.R., Testa J.R. Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet. 43:(1):1989;1-14.
2. Pejovic T., Heim S., Mandahl N., Baldetorp B., Elmfors B., Floderus U.M., Furgyik S., Helm G., Himmelmann A., Willen H. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer. 4:(1):1992;58-68.
3. Kiechle M., Bauknecht T., Schmidt J., Walz L., Pfleiderer A. Recurrent cytogenetic aberrations in human ovarian carcinomas. Cancer Detect Prev. 19:(3):1995;234-243.
4. Izutsu T., Kudo T., Shoji T., Nishiya I. Comparative cytogenetic studies of benign, borderline, and malignant epithelial ovarian tumors. J Obstet Gynaecol Res. 22:(6):1996;541-549.
5. Deger R.B., Faruqi S.A., Noumoff J.S. Karyotypic analysis of 32 malignant epithelial ovarian tumors. Cancer Genet Cytogenet. 96:(2):1997;166-173.
6. Taetle R., Aickin M., Yang J.M., Panda L., Emerson J., Roe D., Adair L., Thompson F., Liu Y., Wisner L., Davis J.R., Trent J., Alberts D.S. Chromosome abnormalities in ovarian adenocarcinoma I. Nonrandom chromosome abnormalities from 244 cases . Genes Chromosomes Cancer. 25:(3):1999;290-300.
7. Suzuki S., Moore D.H. 2nd, Ginzinger D.G., Godfrey T.E., Barclay J., Powell B., Pinkel D., Zaloudek C., Lu K., Mills G., Berchuck A., Gray J.W. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 60:(19):2000;5382-5385.
8. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.Y., Carcangiu M.L., Pinkel D., Yang-Feng T.L., Gray J.W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55:(24):1995;6172-6180.
9. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., Kiechle M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer. 16:(1):1996;46-54.
10. Sonoda G., Palazzo J., du Manoir S., Godwin A.K., Feder M., Yakushiji M., Testa J.R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer. 20:(4):1997;320-328.
11. Patael-Karasik Y., Daniely M., Gotlieb W.H., Ben-Baruch G., Schiby J., Barakai G., Goldman B., Aviram A., Friedman E. Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel. Cancer Genet Cytogenet. 121:(1):2000;26-32.
12. Kiechle M., Jacobsen A., Schwarz-Boeger U., Hedderich J., Pfisterer J., Arnold N. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer. 91:(3):2001;534-540.
13. Tapper J., Butzow R., Wahlstrom T., Seppala M., Knuutila S. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas. Br J Cancer. 75:(12):1997;1782-1787.
14. Hu J., Khanna V., Jones M.W., Surti U. Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet Cytogenet. 139:(1):2002;18-23.
15. Guan X.Y., Sham J.S., Tang T.C., Fang Y., Huo K.K., Yang J.M. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 61:(9):2001;3806-3809.
16. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G.B., Gray J.W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 21:(1):1999;99-102.
17. Thompson F.H., Nelson M.A., Trent J.M., Guan X.Y., Liu Y., Yang J.M., Emerson J., Adair L., Wymer J., Balfour C., Massey K., Weinstein R., Alberts D.S., Taetle R. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet. 87:(1):1996;55-62.
18. Wada N., Duh Q.Y., Miura D., Brunaud L., Wong M.G., Clark O.H. Chromosomal aberrations by comparative genomic hybridization in hurthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab. 87:(10):2002;4595-4601.
19. Suehiro Y., Sakamoto M., Umayahara K., Iwabuchi H., Sakamoto H., Tanaka N., Takeshima N., Yamauchi K., Hasumi K., Akiya T., Sakunaga H., Muroya T., Numa F., Kato H., Tenjin Y., Sugishita T. Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas. Oncology. 59:(1):2000;50-56.
20. Wolf N.G., Abdul-Karim F.W., Farver C., Schrock E., du Manoir S., Schwartz S. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer. 25:(4):1999;307-315.